ISPOR - Cost-Effectiveness Of Efavirenz Compared With Generic Nevirapine In Hiv Patients Initiating First-Line Treatment In The United States

Full Text

Cost-Effectiveness Of Efavirenz Compared With Generic Nevirapine In Hiv Patients Initiating First-Line Treatment In The United States

Abstract

Authors

M.M. Bonafede T. Juday A. Farr G.M. Lenhart T. Hebden T. Correll

Back to Volume 16, Issue 3

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now